The present study unveils a crucial role of iSGLT2 in glucose metabolism and metabolic energetic reprogramming in CRC tumorigenesis, suggesting a dynamic interplay among metabolic alteration, damaged mitochondrial bioenergetic machinery, and the induction of programmed cell death mechanisms in response to SGLT2 suppression. This evidence concerns the gene SLC5A2 and colorectal carcinoma.